Recent Update on the Role of Circular RNAs in Hepatocellular Carcinoma

References

• Petrick JL, Braunlin M, Laversanne M, Valery PC, Bray F, McGlynn KA. International trends in liver cancer incidence, overall and by histologic subtype, 1978-2007. Int J Cancer. 2016;139(7):1534–1545. doi:10.1002/ijc.30211
   PubMed Web of Science ®Google Scholar
• Petrick JL, McGlynn KA. The changing epidemiology of primary liver cancer. Curr Epidemiol Rep. 2019;6(2):104–111. doi:10.1007/s40471-019-00188-3
   PubMedGoogle Scholar
• Cha C, DeMatteo RP. Molecular mechanisms in hepatocellular carcinoma development. Best Pract Res Clin Gastroenterol. 2005;19(1):25–37. doi:10.1016/j.bpg.2004.11.005
   PubMed Web of Science ®Google Scholar
• Hu J, Protzer U, Siddiqui A. Revisiting Hepatitis B virus: challenges of curative therapies. J Virol. 2019;93:20. doi:10.1128/JVI.01032-19
   Web of Science ®Google Scholar
• Revill PA, Chisari FV, Block JM, et al. A global scientific strategy to cure hepatitis B. Lancet Gastroenterol Hepatol. 2019;4(7):545–558. doi:10.1016/S2468-1253(19)30119-0
   PubMed Web of Science ®Google Scholar
• Chang MH, You SL, Chen CJ, et al. Long-term Effects of Hepatitis B immunization of infants in preventing liver cancer. Gastroenterology. 2016;151(3):472–480. doi:10.1053/j.gastro.2016.05.048
   PubMed Web of Science ®Google Scholar
• de Oliveria Andrade LJ, D’Oliveira A, Melo RC, De Souza EC, Costa Silva CA, Parana R. Association between hepatitis C and hepatocellular carcinoma. J Glob Infect Dis. 2009;1(1):33–37. doi:10.4103/0974-777X.52979
   PubMedGoogle Scholar
• Ringelhan M, McKeating JA, Protzer U. Viral hepatitis and liver cancer. Philos Trans R Soc Lond B Biol Sci. 2017;372:1732. doi:10.1098/rstb.2016.0274
   Web of Science ®Google Scholar
• Wu HC, Santella R. The role of aflatoxins in hepatocellular carcinoma. Hepat Mon. 2012;12(10HCC):e7238. doi:10.5812/hepatmon.7238
   Web of Science ®Google Scholar
• Baffy G, Brunt EM, Caldwell SH. Hepatocellular carcinoma in non-alcoholic fatty liver disease: an emerging menace. J Hepatol. 2012;56(6):1384–1391. doi:10.1016/j.jhep.2011.10.027
   PubMed Web of Science ®Google Scholar
• Marrero JA, Kulik LM, Sirlin CB, et al. Diagnosis, staging, and management of hepatocellular carcinoma: 2018 practice guidance by the american association for the study of liver diseases. Hepatology. 2018;68(2):723–750. doi:10.1002/hep.29913
   PubMed Web of Science ®Google Scholar
• Liu CY, Chen KF, Chen PJ. Treatment of liver cancer. Cold Spring Harb Perspect Med. 2015;5(9):a021535. doi:10.1101/cshperspect.a021535
   PubMed Web of Science ®Google Scholar
• Llovet JM, Ricci S, Mazzaferro V, et al. Sorafenib in advanced hepatocellular carcinoma. N Engl J Med. 2008;359(4):378–390. doi:10.1056/NEJMoa0708857
   PubMed Web of Science ®Google Scholar
• Zhang P, Wu W, Chen Q, Chen M. Non-Coding RNAs and their integrated networks. J Integr Bioinform. 2019;16:3. doi:10.1515/jib-2019-0027
   Web of Science ®Google Scholar
• Wang Y, Wang Z. Efficient backsplicing produces translatable circular mRNAs. RNA. 2015;21(2):172–179. doi:10.1261/rna.048272.114
   PubMed Web of Science ®Google Scholar
• Hsu MT, Coca-Prados M. Electron microscopic evidence for the circular form of RNA in the cytoplasm of eukaryotic cells. Nature. 1979;280(5720):339–340. doi:10.1038/280339a0
   PubMed Web of Science ®Google Scholar
• Memczak S, Jens M, Elefsinioti A, et al. Circular RNAs are a large class of animal RNAs with regulatory potency. Nature. 2013;495(7441):333–338. doi:10.1038/nature11928
   PubMed Web of Science ®Google Scholar
• Hansen TB, Jensen TI, Clausen BH, et al. Natural RNA circles function as efficient microRNA sponges. Nature. 2013;495(7441):384–388. doi:10.1038/nature11993
   PubMed Web of Science ®Google Scholar
• Kristensen LS, Hansen TB, Veno MT, Kjems J. Circular RNAs in cancer: opportunities and challenges in the field. Oncogene. 2018;37(5):555–565. doi:10.1038/onc.2017.361
   PubMed Web of Science ®Google Scholar
• Zhang H, Shen Y, Li Z, et al. The biogenesis and biological functions of circular RNAs and their molecular diagnostic values in cancers. J Clin Lab Anal. 2020;34(1):e23049.
   Web of Science ®Google Scholar
• Holdt LM, Kohlmaier A, Teupser D. Circular RNAs as therapeutic agents and targets. Front Physiol. 2018;9:1262. doi:10.3389/fphys.2018.01262
   PubMed Web of Science ®Google Scholar
• Holdt LM, Kohlmaier A, Teupser D. Molecular roles and function of circular RNAs in eukaryotic cells. Cell Mol Life Sci. 2018;75(6):1071–1098. doi:10.1007/s00018-017-2688-5
   PubMed Web of Science ®Google Scholar
• Kristensen LS, Andersen MS, Stagsted LVW, Ebbesen KK, Hansen TB, Kjems J. The biogenesis, biology and characterization of circular RNAs. Nat Rev Genet. 2019;20(11):675–691. doi:10.1038/s41576-019-0158-7
   PubMed Web of Science ®Google Scholar
• Starke S, Jost I, Rossbach O, et al. Exon circularization requires canonical splice signals. Cell Rep. 2015;10(1):103–111. doi:10.1016/j.celrep.2014.12.002
   PubMed Web of Science ®Google Scholar
• Conn SJ, Pillman KA, Toubia J, et al. The RNA binding protein quaking regulates formation of circRNAs. Cell. 2015;160(6):1125–1134. doi:10.1016/j.cell.2015.02.014
   PubMed Web of Science ®Google Scholar
• Errichelli L, Dini Modigliani S, Laneve P, et al. FUS affects circular RNA expression in murine embryonic stem cell-derived motor neurons. Nat Commun. 2017;8:14741. doi:10.1038/ncomms14741
   PubMed Web of Science ®Google Scholar
• Szabo L, Salzman J. Detecting circular RNAs: bioinformatic and experimental challenges. Nat Rev Genet. 2016;17(11):679–692. doi:10.1038/nrg.2016.114
   PubMed Web of Science ®Google Scholar
• Zhang XO, Wang HB, Zhang Y, Lu X, Chen LL, Yang L. Complementary sequence-mediated exon circularization. Cell. 2014;159(1):134–147. doi:10.1016/j.cell.2014.09.001
   PubMed Web of Science ®Google Scholar
• Liu Q, Cai Y, Xiong H, Deng Y, Dai X. CCRDB: a cancer circRNAs-related database and its application in hepatocellular carcinoma-related circRNAs. Database (Oxford). 2019;2019:2019. doi:10.1093/database/baz063
   Web of Science ®Google Scholar
• Rophina M, Sharma D, Poojary M, Scaria V. Circad: a comprehensive manually curated resource of circular RNA associated with diseases. Database (Oxford). 2020;2020:2020. doi:10.1093/database/baaa019
   Web of Science ®Google Scholar
• Rupaimoole R, Calin GA, Lopez-Berestein G, Sood AK. miRNA deregulation in cancer cells and the tumor microenvironment. Cancer Discov. 2016;6(3):235–246. doi:10.1158/2159-8290.CD-15-0893
   PubMed Web of Science ®Google Scholar
• Shang X, Li G, Liu H, et al. Comprehensive Circular RNA profiling reveals that hsa_circ_0005075, a new circular RNA biomarker, is involved in hepatocellular crcinoma development. Medicine (Baltimore). 2016;95(22):e3811. doi:10.1097/MD.0000000000003811
   PubMed Web of Science ®Google Scholar
• Cao S, Wang G, Wang J, Li C, Zhang L. Hsa_circ_101280 promotes hepatocellular carcinoma by regulating miR-375/JAK2. Immunol Cell Biol. 2019;97(2):218–228. doi:10.1111/imcb.12213
   PubMed Web of Science ®Google Scholar
• Cao Y, Tao Q, Kao X, Zhu X. Hsa-circRNA-103809 promotes hepatocellular carcinoma development via MicroRNA-1270/PLAG1 like zinc Finger 2 axis. Dig Dis Sci. 2020. doi:10.1007/s10620-020-06416-x
   Web of Science ®Google Scholar
• Chen Z, Zuo X, Pu L, et al. circLARP4 induces cellular senescence through regulating miR-761/RUNX3/p53/p21 signaling in hepatocellular carcinoma. Cancer Sci. 2019;110(2):568–581. doi:10.1111/cas.13901
   Web of Science ®Google Scholar
• Ding B, Fan W, Lou W. hsa_circ_0001955 enhances in vitro proliferation, migration, and invasion of HCC cells through miR-145-5p/NRAS axis. Molecular Therapy - Nucleic Acids. 2020;22:445–455. doi:10.1016/j.omtn.2020.09.007
   Google Scholar
• Ding Z, Guo L, Deng Z, Li P. Circ-PRMT5 enhances the proliferation, migration and glycolysis of hepatoma cells by targeting miR-188-5p/HK2 axis. Ann Hepatol. 2020;19(3):269–279. doi:10.1016/j.aohep.2020.01.002
   PubMed Web of Science ®Google Scholar
• Fang Q, Liu H, Zhou A, Zhou H, Zhang Z. Circ_0046599 promotes the development of hepatocellular carcinoma by regulating the miR-1258/RPN2 network. Cancer Manag Res. 2020;12:6849–6860. doi:10.2147/CMAR.S253510
   PubMed Web of Science ®Google Scholar
• Fu X, Zhang J, He X, et al. Circular RNA MAN2B2 promotes cell proliferation of hepatocellular carcinoma cells via the miRNA-217/MAPK1 axis. J Cancer. 2020;11(11):3318–3326. doi:10.7150/jca.36500
   PubMed Web of Science ®Google Scholar
• Fu Y, Cai L, Lei X, Wang D. Circular RNA ABCB10 promotes hepatocellular carcinoma progression by increasing HMG20A expression by sponging miR-670-3p. Cancer Cell Int. 2019;19:338. doi:10.1186/s12935-019-1055-z
   PubMed Web of Science ®Google Scholar
• Gao J, Dai C, Yu X, Yin XB, Zhou F. Circ-TCF4.85 silencing inhibits cancer progression through microRNA-486-5p-targeted inhibition of ABCF2 in hepatocellular carcinoma. Mol Oncol. 2020;14(2):447–461. doi:10.1002/1878-0261.12603
   PubMed Web of Science ®Google Scholar
• Gao J, Li E, Liu W, et al. Circular RNA MYLK promotes hepatocellular carcinoma progression through the miR29a/KMT5C signaling pathway. Onco Targets Ther. 2020;13:8615–8627. doi:10.2147/OTT.S258715
   PubMed Web of Science ®Google Scholar
• Guo J, Duan H, Li Y, Yang L, Yuan L. A novel circular RNA circ-ZNF652 promotes hepatocellular carcinoma metastasis through inducing snail-mediated epithelial-mesenchymal transition by sponging miR-203/miR-502-5p. Biochem Biophys Res Commun. 2019;513(4):812–819. doi:10.1016/j.bbrc.2019.03.214
   PubMed Web of Science ®Google Scholar
• Guo W, Zhao L, Wei G, Liu P, Zhang Y, Fu L. Circ_0015756 aggravates hepatocellular carcinoma development by regulating FGFR1 via sponging miR-610. Cancer Manag Res. 2020;12:7383–7394. doi:10.2147/CMAR.S262231
   Web of Science ®Google Scholar
• Guo X, Jin W, Chang C, et al. Large-scale quantitative genomics analyzes the circRNA expression profile and identifies the key circRNA in regulating cell proliferation during the proliferation phase of rat LR. Artif Cells Nanomed Biotechnol. 2019;47(1):2957–2966. doi:10.1080/21691401.2019.1640710
   PubMed Web of Science ®Google Scholar
• He S, Guo Z, Kang Q, Wang X, Han X. Circular RNA hsa_circ_0000517 modulates hepatocellular carcinoma advancement via the miR-326/SMAD6 axis. Cancer Cell Int. 2020;20:360. doi:10.1186/s12935-020-01447-w
   PubMed Web of Science ®Google Scholar
• He S, Yang J, Jiang S, Li Y, Han X. Circular RNA circ_0000517 regulates hepatocellular carcinoma development via miR-326/IGF1R axis. Cancer Cell Int. 2020;20:404. doi:10.1186/s12935-020-01496-1
   PubMed Web of Science ®Google Scholar
• Jia B, Yin X, Wang Y, et al. CircRNA-PTN sponges miR-326 to promote proliferation in hepatocellular carcinoma. Onco Targets Ther. 2020;13:4893–4903. doi:10.2147/OTT.S251300
   PubMed Web of Science ®Google Scholar
• Jia C, Yao Z, Lin Z, et al. circNFATC3 sponges miR-548I acts as a ceRNA to protect NFATC3 itself and suppressed hepatocellular carcinoma progression. J Cell Physiol. 2020;236(2):1252–1269. doi:10.1002/jcp.29931
   Web of Science ®Google Scholar
• Jiang QL, Feng SJ, Yang ZY, Xu Q, Wang SZ. CircHECTD1 up-regulates mucin 1 expression to accelerate hepatocellular carcinoma development by targeting microRNA-485-5p via a competing endogenous RNA mechanism. Chin Med J (Engl). 2020;133(15):1774–1785. doi:10.1097/CM9.0000000000000917
   Web of Science ®Google Scholar
• Jin J, Liu H, Jin M, Li W, Xu H, Wei F. Silencing of hsa_circ_0101145 reverses the epithelial-mesenchymal transition in hepatocellular carcinoma via regulation of the miR-548c-3p/LAMC2 axis. Aging (Albany NY). 2020;12(12):11623–11635. doi:10.18632/aging.103324
   Google Scholar
• Li D, Zhang J, Li J. Role of miRNA sponges in hepatocellular carcinoma. Clin Chim Acta. 2020;500:10–19. doi:10.1016/j.cca.2019.09.013
   PubMed Web of Science ®Google Scholar
• Li J, Qin X, Wu R, Wan L, Zhang L, Liu R. Circular RNA circFBXO11 modulates hepatocellular carcinoma progress and oxaliplatin resistance through miR-605/FOXO3/ABCB1 axis. J Cell Mol Med. 2020;24(9):5152–5161. doi:10.1111/jcmm.15162
   PubMed Web of Science ®Google Scholar
• Li Q, Pan X, Zhu D, Deng Z, Jiang R, Wang X. Circular RNA MAT2B promotes glycolysis and malignancy of hepatocellular carcinoma through the miR-338-3p/PKM2 axis under hypoxic stress. Hepatology. 2019;70(4):1298–1316. doi:10.1002/hep.30671
   PubMed Web of Science ®Google Scholar
• Li S, Weng J, Song F, et al. Circular RNA circZNF566 promotes hepatocellular carcinoma progression by sponging miR-4738-3p and regulating TDO2 expression. Cell Death Dis. 2020;11(6):452. doi:10.1038/s41419-020-2616-8
   Web of Science ®Google Scholar
• Li X, Shen M. Circular RNA hsa_circ_103809 suppresses hepatocellular carcinoma proliferation and invasion by sponging miR-620. Eur Rev Med Pharmacol Sci. 2019;23(2):555–566. doi:10.26355/eurrev_201902_16868
   Web of Science ®Google Scholar
• Li Y, Shi H, Yuan J, Qiao L, Dong L, Wang Y. Downregulation of circular RNA circPVT1 restricts cell growth of hepatocellular carcinoma through downregulation of Sirtuin 7 via microRNA-3666. Clin Exp Pharmacol Physiol. 2020;47(7):1291–1300. doi:10.1111/1440-1681.13273
   PubMed Web of Science ®Google Scholar
• Li Z, Hu Y, Zeng Q, et al. Circular RNA MYLK promotes hepatocellular carcinoma progression by increasing Rab23 expression by sponging miR-362-3p. Cancer Cell Int. 2019;19:211. doi:10.1186/s12935-019-0926-7
   PubMed Web of Science ®Google Scholar
• Li Z, Liu Y, Yan J, et al. Circular RNA hsa_circ_0056836 functions an oncogenic gene in hepatocellular carcinoma through modulating miR-766-3p/FOSL2 axis. Aging (Albany NY). 2020;12(3):2485–2497. doi:10.18632/aging.102756
   Google Scholar
• Liao X, Zhan W, Tian B, Luo Y, Gu F, Li R. Circular RNA ZNF609 promoted hepatocellular carcinoma progression by upregulating PAP2C expression via sponging miR-342-3p. Onco Targets Ther. 2020;13:7773–7783. doi:10.2147/OTT.S253936
   PubMed Web of Science ®Google Scholar
• Lin T, Dai Y, Guo X, et al. Silencing of hsa_circ_0008450 represses hepatocellular carcinoma progression through regulation of microRNA-214-3p/EZH2 axis. Cancer Manag Res. 2019;11:9133–9143. doi:10.2147/CMAR.S222716
   PubMed Web of Science ®Google Scholar
• Lin Y, Huang G, Jin H, Jian Z. Circular RNA Gprc5a Promotes HCC progression by activating YAP1/TEAD1 signalling pathway by sponging miR-1283. Onco Targets Ther. 2020;13:4509–4521. doi:10.2147/OTT.S240261
   PubMed Web of Science ®Google Scholar
• Liu C, Zhong X, Li J, Xu F. Circular RNA circVAPA promotes cell proliferation in hepatocellular carcinoma. Hum Gene Ther Clin Dev. 2019;30(4):152–159. doi:10.1089/humc.2019.079
   Web of Science ®Google Scholar
• Liu L, Qi X, Gui Y, Huo H, Yang X, Yang L. Overexpression of circ_0021093 circular RNA forecasts an unfavorable prognosis and facilitates cell progression by targeting the miR-766-3p/MTA3 pathway in hepatocellular carcinoma. Gene. 2019;714:143992. doi:10.1016/j.gene.2019.143992
   Web of Science ®Google Scholar
• Liu L, Yang X, Li NF, Lin L, Luo H. Circ_0015756 promotes proliferation, invasion and migration by microRNA-7-dependent inhibition of FAK in hepatocellular carcinoma. Cell Cycle. 2019;18(21):2939–2953. doi:10.1080/15384101.2019.1664223
   PubMed Web of Science ®Google Scholar
• Liu W, Yin C, Liu Y. Circular RNA circ_0091579 promotes hepatocellular carcinoma proliferation, migration, invasion, and glycolysis through miR-490-5p/CASC3 axis. Cancer Biother Radiopharm. 2020. doi:10.1089/cbr.2019.3472
   Web of Science ®Google Scholar
• Liu X, Yang L, Jiang D, Lu W, Zhang Y. Circ-DENND4C up-regulates TCF4 expression to modulate hepatocellular carcinoma cell proliferation and apoptosis via activating Wnt/beta-catenin signal pathway. Cancer Cell Int. 2020;20:295. doi:10.1186/s12935-020-01346-0
   Web of Science ®Google Scholar
• Liu Z, Yu Y, Huang Z, et al. CircRNA-5692 inhibits the progression of hepatocellular carcinoma by sponging miR-328-5p to enhance DAB2IP expression. Cell Death Dis. 2019;10(12):900. doi:10.1038/s41419-019-2089-9
   PubMed Web of Science ®Google Scholar
• Pan H, Tang L, Jiang H, et al. Enhanced expression of circ_0000267 in hepatocellular carcinoma indicates poor prognosis and facilitates cell progression by sponging miR-646. J Cell Biochem. 2019;120(7):11350–11357. doi:10.1002/jcb.28411
   PubMed Web of Science ®Google Scholar
• Pu J, Wang J, Li W, et al. hsa_circ_0000092 promotes hepatocellular carcinoma progression through up-regulating HN1 expression by binding to microRNA-338-3p. J Cell Mol Med. 2020. doi:10.1111/jcmm.15010
   Web of Science ®Google Scholar
• Qiu L, Huang Y, Li Z, et al. Circular RNA profiling identifies circADAMTS13 as a miR-484 sponge which suppresses cell proliferation in hepatocellular carcinoma. Mol Oncol. 2019;13(2):441–455. doi:10.1002/1878-0261.12424
   PubMed Web of Science ®Google Scholar
• Qiu L, Wang T, Ge Q, et al. Circular RNA signature in hepatocellular carcinoma. J Cancer. 2019;10(15):3361–3372. doi:10.7150/jca.31243
   PubMed Web of Science ®Google Scholar
• Song LN, Qiao GL, Yu J, et al. Hsa_circ_0003998 promotes epithelial to mesenchymal transition of hepatocellular carcinoma by sponging miR-143-3p and PCBP1. J Exp Clin Cancer Res. 2020;39(1):114. doi:10.1186/s13046-020-01576-0
   PubMed Web of Science ®Google Scholar
• Su Y, Lv X, Yin W, et al. CircRNA Cdr1as functions as a competitive endogenous RNA to promote hepatocellular carcinoma progression. Aging (Albany NY). 2019;11(19):8182–8203. doi:10.18632/aging.102312
   Google Scholar
• Sun C, Li G, Liu M. A novel circular RNA, circ_0005394, predicts unfavorable prognosis and contributes to hepatocellular carcinoma progression by regulating miR-507/E2F3 and miR-515-5p/CXCL6 signaling pathways. Onco Targets Ther. 2020;13:6171–6180. doi:10.2147/OTT.S256238
   PubMed Web of Science ®Google Scholar
• Sun P, Fan X, Hu X, Fu X, Wei Q, Zang Y. circPCNX and pecanex promote hepatocellular carcinoma cell viability by inhibiting miR-506. Cancer Manag Res. 2019;11:10957–10967. doi:10.2147/CMAR.S232940
   PubMed Web of Science ®Google Scholar
• Sun Q, Yu R, Wang C, Yao J, Zhang L. Correction to: circular RNA circ-CSPP1 regulates CCNE2 to facilitate hepatocellular carcinoma cell growth via sponging miR-577. Cancer Cell Int. 2020;20:293. doi:10.1186/s12935-020-01339-z
   Web of Science ®Google Scholar
• Sun Q, Yu R, Wang C, Yao J, Zhang L. Circular RNA circ-CSPP1 regulates CCNE2 to facilitate hepatocellular carcinoma cell growth via sponging miR-577. Cancer Cell Int. 2020;20:202. doi:10.1186/s12935-020-01287-8
   Web of Science ®Google Scholar
• Tian F, Yu C, Wu M, Wu X, Wan L, Zhu X. MicroRNA-191 promotes hepatocellular carcinoma cell proliferation by has_circ_0000204/miR-191/KLF6 axis. Cell Prolif. 2019;52(5):e12635. doi:10.1111/cpr.12635
   Web of Science ®Google Scholar
• Wang W, Li Y, Li X, et al. Circular RNA circ-FOXP1 induced by SOX9 promotes hepatocellular carcinoma progression via sponging miR-875-3p and miR-421. Biomed Pharmacother. 2020;121:109517. doi:10.1016/j.biopha.2019.109517
   PubMed Web of Science ®Google Scholar
• Wei X, Zheng W, Tian P, et al. Oncogenic hsa_circ_0091581 promotes the malignancy of HCC cell through blocking miR-526b from degrading c-MYC mRNA. Cell Cycle. 2020;19(7):817–824. doi:10.1080/15384101.2020.1731945
   PubMed Web of Science ®Google Scholar
• Xie B, Zhao Z, Liu Q, Wang X, Ma Z, Li H. CircRNA has_circ_0078710 acts as the sponge of microRNA-31 involved in hepatocellular carcinoma progression. Gene. 2019;683:253–261. doi:10.1016/j.gene.2018.10.043
   PubMed Web of Science ®Google Scholar
• Yang J, Li Y, Yu Z, et al. Circular RNA Circ100084 functions as sponge of miR23a5p to regulate IGF2 expression in hepatocellular carcinoma. Mol Med Rep. 2020;21(6):2395–2404. doi:10.3892/mmr.2020.11069
   Web of Science ®Google Scholar
• Yang W, Ju HY, Tian XF. Circular RNA-ABCB10 suppresses hepatocellular carcinoma progression through upregulating NRP1/ABL2 via sponging miR-340-5p/miR-452-5p. Eur Rev Med Pharmacol Sci. 2020;24(5):2347–2357. doi:10.26355/eurrev_202003_20501
   Web of Science ®Google Scholar
• Yao Z, Xu R, Yuan L, et al. Circ_0001955 facilitates hepatocellular carcinoma (HCC) tumorigenesis by sponging miR-516a-5p to release TRAF6 and MAPK11. Cell Death Dis. 2019;10(12):945. doi:10.1038/s41419-019-2176-y
   PubMed Web of Science ®Google Scholar
• Yu X, Sheng P, Sun J, et al. The circular RNA circMAST1 promotes hepatocellular carcinoma cell proliferation and migration by sponging miR-1299 and regulating CTNND1 expression. Cell Death Dis. 2020;11(5):340. doi:10.1038/s41419-020-2532-y
   PubMed Web of Science ®Google Scholar
• Zang H, Li Y, Zhang X, Huang G. Circ_0000517 contributes to hepatocellular carcinoma progression by upregulating TXNDC5 via Sponging miR-1296-5p. Cancer Manag Res. 2020;12:3457–3468. doi:10.2147/CMAR.S244024
   PubMed Web of Science ®Google Scholar
• Zhang PF, Wei CY, Huang XY, et al. Circular RNA circTRIM33-12 acts as the sponge of MicroRNA-191 to suppress hepatocellular carcinoma progression. Mol Cancer. 2019;18(1):105. doi:10.1186/s12943-019-1031-1
   PubMed Web of Science ®Google Scholar
• Zhang S, Liu Y, Liu Z, et al. CircRNA_0000502 promotes hepatocellular carcinoma metastasis and inhibits apoptosis through targeting microRNA-124. J BUON. 2019;24(6):2402–2410.
   PubMed Web of Science ®Google Scholar
• Zhang W, Zhu L, Yang G, et al. Hsa_circ_0026134 expression promoted TRIM25- and IGF2BP3-mediated hepatocellular carcinoma cell proliferation and invasion via sponging miR-127-5p. Biosci Rep. 2020;40:7.
   Google Scholar
• Zhao M, Dong G, Meng Q, Lin S, Li X. Circ-HOMER1 enhances the inhibition of miR-1322 on CXCL6 to regulate the growth and aggressiveness of hepatocellular carcinoma cells. J Cell Biochem. 2020;121(11):4440–4449. doi:10.1002/jcb.29672
   PubMed Web of Science ®Google Scholar
• Zou H, Xu X, Luo L, et al. Hsa_circ_0101432 promotes the development of hepatocellular carcinoma (HCC) by adsorbing miR-1258 and miR-622. Cell Cycle. 2019;18(19):2398–2413. doi:10.1080/15384101.2019.1618120
   PubMed Web of Science ®Google Scholar
• Wang G, Liu W, Zou Y, et al. Three isoforms of exosomal circPTGR1 promote hepatocellular carcinoma metastasis via the miR449a-MET pathway. EBioMedicine. 2019;40:432–445. doi:10.1016/j.ebiom.2018.12.062
   PubMed Web of Science ®Google Scholar
• Tan A, Li Q, Chen L. CircZFR promotes hepatocellular carcinoma progression through regulating miR-3619-5p/CTNNB1 axis and activating Wnt/beta-catenin pathway. Arch Biochem Biophys. 2019;661:196–202. doi:10.1016/j.abb.2018.11.020
   PubMed Web of Science ®Google Scholar
• Wang F, Xu X, Zhang N, Chen Z. Identification and integrated analysis of hepatocellular carcinoma-related circular RNA signature. Ann Transl Med. 2020;8(6):294. doi:10.21037/atm.2020.03.06
   PubMed Web of Science ®Google Scholar
• Yang C, Dong Z, Hong H, et al. circFN1 mediates sorafenib resistance of hepatocellular carcinoma cells by sponging miR-1205 and regulating E2F1 expression. Molecular Therapy - Nucleic Acids. 2020;22:421–433. doi:10.1016/j.omtn.2020.08.039
   Google Scholar
• Wei Y, Chen X, Liang C, et al. A noncoding regulatory RNAs network driven by Circ-CDYL acts specifically in the early stages hepatocellular carcinoma. Hepatology. 2020;71(1):130–147. doi:10.1002/hep.30795
   PubMed Web of Science ®Google Scholar
• Wu J, Liu S, Xiang Y, Qu X, Xie Y, Zhang X. Bioinformatic analysis of circular RNA-Associated ceRNA network associated with hepatocellular carcinoma. Biomed Res Int. 2019;2019:8308694. doi:10.1155/2019/8308694
   PubMed Web of Science ®Google Scholar
• Xu Q, Zhou L, Yang G, et al. CircIL4R facilitates the tumorigenesis and inhibits ferroptosis in hepatocellular carcinoma by regulating the miR-541-3p/GPX4 axis. Cell Biol Int. 2020;44(11):2344–2356. doi:10.1002/cbin.11444
   PubMed Web of Science ®Google Scholar
• Yang G, Wang X, Liu B, et al. circ-BIRC6, a circular RNA, promotes hepatocellular carcinoma progression by targeting the miR-3918/Bcl2 axis. Cell Cycle. 2019;18(9):976–989. doi:10.1080/15384101.2019.1601477
   PubMed Web of Science ®Google Scholar
• Yu J, Yang M, Zhou B, et al. CircRNA-104718 acts as competing endogenous RNA and promotes hepatocellular carcinoma progression through microRNA-218-5p/TXNDC5 signaling pathway. Clin Sci (Lond). 2019;133(13):1487–1503. doi:10.1042/CS20190394
   PubMed Web of Science ®Google Scholar
• Zhang T, Zhang L, Han D, Tursun K, Lu X. Circular RNA hsa_Circ_101141 as a competing endogenous RNA facilitates tumorigenesis of hepatocellular carcinoma by regulating miR-1297/ROCK1 pathway. Cell Transplant. 2020;29:963689720948016. doi:10.1177/0963689720948016
   Web of Science ®Google Scholar
• Zhu Y, Liu Y, Xiao B, et al. The circular RNA PVT1/miR-203/HOXD3 pathway promotes the progression of human hepatocellular carcinoma. Biol Open. 2019;8:9. doi:10.1242/bio.043687
   Web of Science ®Google Scholar
• Wang Y, Gao R, Li J, et al. Circular RNA hsa_circ_0003141 promotes tumorigenesis of hepatocellular carcinoma via a miR-1827/UBAP2 axis. Aging (Albany NY). 2020;12(10):9793–9806. doi:10.18632/aging.103244
   PubMedGoogle Scholar
• Zhan W, Liao X, Chen Z, et al. Circular RNA hsa_circRNA_103809 promoted hepatocellular carcinoma development by regulating miR-377-3p/FGFR1/ERK axis. J Cell Physiol. 2020;235(2):1733–1745. doi:10.1002/jcp.29092
   PubMed Web of Science ®Google Scholar
• Wang L, Long H, Zheng Q, Bo X, Xiao X, Li B. Circular RNA circRHOT1 promotes hepatocellular carcinoma progression by initiation of NR2F6 expression. Mol Cancer. 2019;18(1):119. doi:10.1186/s12943-019-1046-7
   PubMed Web of Science ®Google Scholar
• Clough E, Barrett T. The gene expression omnibus database. Methods Mol Biol. 2016;1418:93–110.
   PubMedGoogle Scholar
• Wang M, Yang Y, Yang J, Yang J, Han S. circ_KIAA1429 accelerates hepatocellular carcinoma advancement through the mechanism of m(6)A-YTHDF3-Zeb1. Life Sci. 2020;257:118082. doi:10.1016/j.lfs.2020.118082
   PubMed Web of Science ®Google Scholar
• Eger A, Aigner K, Sonderegger S, et al. DeltaEF1 is a transcriptional repressor of E-cadherin and regulates epithelial plasticity in breast cancer cells. Oncogene. 2005;24(14):2375–2385. doi:10.1038/sj.onc.1208429
   PubMed Web of Science ®Google Scholar
• Zhu YJ, Zheng B, Luo GJ, et al. Circular RNAs negatively regulate cancer stem cells by physically binding FMRP against CCAR1 complex in hepatocellular carcinoma. Theranostics. 2019;9(12):3526–3540. doi:10.7150/thno.32796
   PubMed Web of Science ®Google Scholar
• Liang WC, Wong CW, Liang PP, et al. Translation of the circular RNA circbeta-catenin promotes liver cancer cell growth through activation of the Wnt pathway. Genome Biol. 2019;20(1):84. doi:10.1186/s13059-019-1685-4
   PubMed Web of Science ®Google Scholar
• Ding J, Zhou W, Li X, Sun M, Ding J, Tandem ZQ. DNAzyme for double digestion: a new tool for circRNA suppression. Biol Chem. 2019;400(2):247–253. doi:10.1515/hsz-2018-0232
   PubMed Web of Science ®Google Scholar
• Wu MY, Tang YP, Liu JJ, Liang R, Luo XL. Global transcriptomic study of circRNAs expression profile in sorafenib resistant hepatocellular carcinoma cells. J Cancer. 2020;11(10):2993–3001. doi:10.7150/jca.39854
   Web of Science ®Google Scholar
• Xiong DD, Feng ZB, Lai ZF, et al. High throughput circRNA sequencing analysis reveals novel insights into the mechanism of nitidine chloride against hepatocellular carcinoma. Cell Death Dis. 2019;10(9):658. doi:10.1038/s41419-019-1890-9
   PubMed Web of Science ®Google Scholar
• O’Rourke JM, Sagar VM, Shah T, Shetty S. Carcinogenesis on the background of liver fibrosis: implications for the management of hepatocellular cancer. World J Gastroenterol. 2018;24(39):4436–4447. doi:10.3748/wjg.v24.i39.4436
   PubMed Web of Science ®Google Scholar
• Jin H, Li C, Dong P, Huang J, Yu J, Zheng J. Circular RNA cMTO1 Promotes PTEN expression through sponging miR-181b-5p in liver fibrosis. Front Cell Dev Biol. 2020;8:714. doi:10.3389/fcell.2020.00714
   Web of Science ®Google Scholar
• Han D, Li J, Wang H, et al. Circular RNA circMTO1 acts as the sponge of microRNA-9 to suppress hepatocellular carcinoma progression. Hepatology. 2017;66(4):1151–1164. doi:10.1002/hep.29270
   PubMed Web of Science ®Google Scholar
• Cheng F, Wang L, Circular ZJ. RNA 0016788 displays as a biomarker for tumor progression and poor prognosis in surgical hepatocellular carcinoma patients. J Clin Lab Anal. 2020;e23300.
   Web of Science ®Google Scholar
• Kou P, Zhang C, Lin J, Wang H. Circular RNA hsa_circ_0078602 may have potential as a prognostic biomarker for patients with hepatocellular carcinoma. Oncol Lett. 2019;17(2):2091–2098. doi:10.3892/ol.2018.9863
   PubMed Web of Science ®Google Scholar
• Lei B, Zhou J, Xuan X, et al. Circular RNA expression profiles of peripheral blood mononuclear cells in hepatocellular carcinoma patients by sequence analysis. Cancer Med. 2019;8(4):1423–1433. doi:10.1002/cam4.2010
   Web of Science ®Google Scholar
• Li Z, Zhou Y, Yang G, et al. Using circular RNA SMARCA5 as a potential novel biomarker for hepatocellular carcinoma. Clin Chim Acta. 2019;492:37–44. doi:10.1016/j.cca.2019.02.001
   PubMed Web of Science ®Google Scholar
• Luo Y, Liu F, Gui R. High expression of circulating exosomal circAKT3 is associated with higher recurrence in HCC patients undergoing surgical treatment. Surg Oncol. 2020;33:276–281. doi:10.1016/j.suronc.2020.04.021
   PubMed Web of Science ®Google Scholar
• Qiao GL, Chen L, Jiang WH, et al. Hsa_circ_0003998 may be used as a new biomarker for the diagnosis and prognosis of hepatocellular carcinoma. Onco Targets Ther. 2019;12:5849–5860. doi:10.2147/OTT.S210363
   PubMed Web of Science ®Google Scholar
• Wu C, Deng L, Zhuo H, et al. Circulating circRNA predicting the occurrence of hepatocellular carcinoma in patients with HBV infection. J Cell Mol Med. 2020;24(17):10216–10222. doi:10.1111/jcmm.15635
   Web of Science ®Google Scholar
• Yu J, Ding WB, Wang MC, et al. Plasma circular RNA panel to diagnose hepatitis B virus-related hepatocellular carcinoma: a large-scale, multicenter study. Int J Cancer. 2020;146(6):1754–1763. doi:10.1002/ijc.32647
   PubMed Web of Science ®Google Scholar
• Zhang J, Chang Y, Xu L, Qin L. Elevated expression of circular RNA circ_0008450 predicts dismal prognosis in hepatocellular carcinoma and regulates cell proliferation, apoptosis, and invasion via sponging miR-548p. J Cell Biochem. 2019;120(6):9487–9494. doi:10.1002/jcb.28224
   Web of Science ®Google Scholar
• Zhou S, Wei J, Wang Y, Liu X. Cisplatin resistance-associated circRNA_101237 serves as a prognostic biomarker in hepatocellular carcinoma. Exp Ther Med. 2020;19(4):2733–2740. doi:10.3892/etm.2020.8526
   PubMed Web of Science ®Google Scholar
• Zhu K, Zhan H, Peng Y, et al. Plasma hsa_circ_0027089 is a diagnostic biomarker for hepatitis B virus-related hepatocellular carcinoma. Carcinogenesis. 2020;41(3):296–302. doi:10.1093/carcin/bgz154
   PubMed Web of Science ®Google Scholar
• Hao Q, Han Y, Xia W, Wang Q, Qian H. Systematic review and meta-analysis of the utility of circular RNAs as biomarkers of hepatocellular carcinoma. Can J Gastroenterol Hepatol. 2019;2019:1684039. doi:10.1155/2019/1684039
   Web of Science ®Google Scholar
• Huang X, Zhang W, Shao Z. Prognostic and diagnostic significance of circRNAs expression in hepatocellular carcinoma patients: A meta-analysis. Cancer Med. 2019;8(3):1148–1156. doi:10.1002/cam4.1939
   Web of Science ®Google Scholar
• Yu G, Yang L, Zhou J, Zhang L, Xia L. Abnormally expressed circular RNAs are promising biomarkers for diagnosis of hepatocellular carcinoma: a meta-analysis. Clin Lab. 2019;65:11. doi:10.7754/Clin.Lab.2019.190354
   Web of Science ®Google Scholar
• Wang Y, Li Z, Xu S, Guo J. Novel potential tumor biomarkers: circular RNAs and exosomal circular RNAs in gastrointestinal malignancies. J Clin Lab Anal. 2020;e23359.
   Web of Science ®Google Scholar
• Li Y, Zhao J, Yu S, et al. Extracellular vesicles long RNA sequencing reveals abundant mRNA, circRNA, and lncRNA in human blood as potential biomarkers for cancer diagnosis. Clin Chem. 2019;65(6):798–808. doi:10.1373/clinchem.2018.301291
   PubMed Web of Science ®Google Scholar
• Zhang PF, Gao C, Huang XY, et al. Cancer cell-derived exosomal circUHRF1 induces natural killer cell exhaustion and may cause resistance to anti-PD1 therapy in hepatocellular carcinoma. Mol Cancer. 2020;19(1):110. doi:10.1186/s12943-020-01222-5
   PubMed Web of Science ®Google Scholar
• Ju Y, Hou N, Meng J, et al. T cell immunoglobulin- and mucin-domain-containing molecule-3 (Tim-3) mediates natural killer cell suppression in chronic hepatitis B. J Hepatol. 2010;52(3):322–329. doi:10.1016/j.jhep.2009.12.005
   PubMed Web of Science ®Google Scholar
• Ma Y, Zhang C, Zhang B, Yu H, Yu Q. circRNA of AR-suppressed PABPC1 91 bp enhances the cytotoxicity of natural killer cells against hepatocellular carcinoma via upregulating UL16 binding protein 1. Oncol Lett. 2019;17(1):388–397. doi:10.3892/ol.2018.9606
   Web of Science ®Google Scholar
• Huang XY, Zhang PF, Wei CY, et al. Circular RNA circMET drives immunosuppression and anti-PD1 therapy resistance in hepatocellular carcinoma via the miR-30-5p/snail/DPP4 axis. Mol Cancer. 2020;19(1):92. doi:10.1186/s12943-020-01213-6
   PubMed Web of Science ®Google Scholar
• Sy SM, Wong N, Lai PB, To KF, Johnson PJ. Regional over-representations on chromosomes 1q, 3q and 7q in the progression of hepatitis B virus-related hepatocellular carcinoma. Mod Pathol. 2005;18(5):686–692. doi:10.1038/modpathol.3800345
   Web of Science ®Google Scholar
• Weng Q, Chen M, Li M, et al. Global microarray profiling identified hsa_circ_0064428 as a potential immune-associated prognosis biomarker for hepatocellular carcinoma. J Med Genet. 2019;56(1):32–38. doi:10.1136/jmedgenet-2018-105440
   PubMed Web of Science ®Google Scholar
• Xia X, Li X, Li F, et al. A novel tumor suppressor protein encoded by circular AKT3 RNA inhibits glioblastoma tumorigenicity by competing with active phosphoinositide-dependent Kinase-1. Mol Cancer. 2019;18(1):131. doi:10.1186/s12943-019-1056-5
   PubMed Web of Science ®Google Scholar
• Yang Y, Gao X, Zhang M, et al. Novel role of FBXW7 circular RNA in repressing glioma tumorigenesis. J Natl Cancer Inst. 2018;110:3. doi:10.1093/jnci/djx166
   Google Scholar
• Zhang M, Huang N, Yang X, et al. A novel protein encoded by the circular form of the SHPRH gene suppresses glioma tumorigenesis. Oncogene. 2018;37(13):1805–1814. doi:10.1038/s41388-017-0019-9
   PubMed Web of Science ®Google Scholar
• Zhang M, Zhao K, Xu X, et al. A peptide encoded by circular form of LINC-PINT suppresses oncogenic transcriptional elongation in glioblastoma. Nat Commun. 2018;9(1):4475. doi:10.1038/s41467-018-06862-2
   PubMed Web of Science ®Google Scholar
• Zheng H, Chen T, Li C, et al. A circular RNA hsa_circ_0079929 inhibits tumor growth in hepatocellular carcinoma. Cancer Manag Res. 2019;11:443–454. doi:10.2147/CMAR.S189338
   PubMed Web of Science ®Google Scholar
• Guo JU, Agarwal V, Guo H, Bartel DP. Expanded identification and characterization of mammalian circular RNAs. Genome Biol. 2014;15(7):409. doi:10.1186/s13059-014-0409-z
   PubMed Web of Science ®Google Scholar